Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro

Food & Function
Ali AljohiNessar Ahmed


Diabetes mellitus characterized by hyperglycemia favors formation of advanced glycation endproducts (AGEs) capable of triggering vascular complications by interfering with imbalanced inflammation and angiogenesis to eventually impede wound-healing. Momordica charantia (MC, bitter melon) has been shown to prevent AGE formation and to promote angiogenesis in diabetic wounds in animal models. However, the mechanism underlying its effects on angiogenesis is unclear. We investigated the effects of methanolic extracts of MC pulp (MCP), flesh (MCF) and charantin (active component of MC) using an in vitro model of angiogenesis. MC extracts or low concentrations of bovine serum albumin-derived AGEs (BSA-AGEs) stimulated proliferation, migration (using wound-healing assay) and tube formation (using Matrigel™-embedded 3D culture) of bovine aortic endothelial cells (BAEC) together with increases in the phosphorylation of extracellular signal-regulated kinase (ERK)1/2, the key angiogenic signaling cytoplasmic protein. Blocking the receptor for AGEs (RAGE) inhibited low BSA-AGE- and MC extract-induced ERK1/2 phosphorylation and tube formation, indicating the crucial role of RAGE in the pro-angiogenic effects of MC extracts. Moreover, inhibit...Continue Reading


Oct 1, 1994·The Journal of Investigative Dermatology·A SattarP Ledger
Aug 1, 1998·Journal of Ethnopharmacology·M Z NaseemR S Patil
Feb 28, 2002·Microvascular Research·Tamami OkamotoKazuo Nagashima
Aug 7, 2003·Journal of Ethnopharmacology·Jaspreet VirdiM K Biyani
Jan 13, 2005·JAMA : the Journal of the American Medical Association·Nalini SinghBenjamin A Lipsky
Jul 20, 2006·Journal of Leukocyte Biology·Min YaoManuela Martins-Green
Feb 28, 2007·Neoplasia : an International Journal for Oncology Research·Sucheta TelangJason Chesney
Apr 30, 2008·Diabetes/metabolism Research and Reviews·Maya S P HuijbertsCasper G Schalkwijk
Sep 16, 2008·Journal of Translational Medicine·Nina A MikirovaNeil H Riordan
Jun 9, 2009·Journal of Ethnopharmacology·Samsul AlamV Satya Prasad
Sep 8, 2009·Comparative Immunology, Microbiology and Infectious Diseases·Henrique D M CoutinhoEdeltrudes O Lima
Oct 15, 2009·The British Journal of Nutrition·Lawrence LeungSharon Cuthbertson
Oct 4, 2011·The Open Medicinal Chemistry Journal·Jaipaul SinghErnest Adeghate
Dec 23, 2011·Molecular Cancer Therapeutics·Hemant K BidPeter J Houghton
Dec 24, 2011·Journal of Medicinal Food·Padmaja Chaturvedi
Jul 21, 2012·The Journal of Dermatological Treatment·Ahmet PişkinMurat Hökelek
Nov 20, 2012·Frontiers in Physiology·Zhongkui HongGabor Forgacs
Aug 24, 2013·Frontiers in Endocrinology·Yasuhiko Yamamoto, Hiroshi Yamamoto
Mar 19, 2014·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Varun Parkash SinghAmteshwar Singh Jaggi
Dec 17, 2016·Advances in Skin & Wound Care·Rekha SinghAshok K Singh

❮ Previous
Next ❯

Methods Mentioned

protein assay

Software Mentioned

Image J
GeneSnap tool

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.